Differences in Optimal Platelet Reactivity after Potent P2Y12 Inhibitor Treatment in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

Background: East Asian patients receiving treatment with the potent P(2)Y(12) inhibitors prasugrel or ticagrelor experience more potent platelet inhibition than with clopidogrel. Methods: This study investigated differences in OPR rates with reduced doses of prasugrel (n = 38) or ticagrelor (n = 40)...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Kai, Jin, Xuan, Kim, Moo-Hyun, Li, Jia-Xin, Jin, Cai-De, Yuan, Song-Lin, Song, Zhao-Yan, Jin, En-Ze, Lee, Kwang-Min, Lim, Kyung-Hee, Cho, Young-Rak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100277/
https://www.ncbi.nlm.nih.gov/pubmed/35566604
http://dx.doi.org/10.3390/jcm11092480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100277/
https://www.ncbi.nlm.nih.gov/pubmed/35566604
http://dx.doi.org/10.3390/jcm11092480

Ejemplares similares